Skip to main content

Table 1 Baseline characteristics of study participants

From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial

Variable

3-Day Routine Change Group

(n = 177)

Clinically Indicated Change Group

(n = 185)

Sex - Male, n (%)

96 (54%)

103 (56%)

Age, mean (SD)

65.1 (17.3)

62.7 (15.4)

Reason for admission, n (%)

  

   • Gastrointestinal

46 (26%)

52 (28%)

   • Respiratory

37 (21%)

34 (18%)

   • Oncology

21 (12%)

21 (11%)

   • Orthopaedic

16 (9%)

22 (12%)

   • Cardiac

10 (6%)

10 (5%)

   • Neurological

9 (5%)

10 (5%)

   • Vascular

7 (4%)

7 (4%)

   • Renal

16 (9%)

9 (5%)

   • Other

15 (8%)

20 (11%)

Number of comorbidities, n (%)

  

   • None

6 (3.4%)

10 (5.4%)

   • 1

22 (12.4%)

21 (11.4%)

   • 2

44 (24.9%)

54 (29.2%)

   • >2

105 (59.3%)

100 (54.1%)

Type of surgery, n (%)

  

   • Nil

124 (70%)

132 (71%)

   • Gastrointestinal

22 (12%)

22 (12%)

   • Orthopaedic

8 (5%)

15 (8%)

   • Other

23 (13%)

16 (9%)

Most recent Hb - Mean (SD)

124.8 (23.2)

126.2 (21.9)